Pune: BJ Govt medical College to check efficacy of ultra-short TB preventive therapy on people with HIV
Post Date:
2024-01-02
Source:
Indian Express
The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.
“Evidence from this study will give insights into the adoption of ultra-short 1HP regimens in Indian settings,” said Dr. Vidya Mave, director and leader of BJGMC JHU Clinical Research Site.
Read More